GLS2 and hepatocellular carcinoma: Next, we assessed GLS2, PTGR1, PLAC8, and CELF6 expression in NUCB2-depleting HCC cells and found that NUCB2 inhibition steadily and significantly decreased PTGR1 mRNA and protein levels (Figures 4D-F).